Suppr超能文献

DNA倍体、增殖指数、分级和分期作为外阴鳞状细胞癌的预后因素。

DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.

作者信息

Dolan J R, McCall A R, Gooneratne S, Walter S, Lansky D M

机构信息

Department of Obstetrics and Gynecology, Loyola University of Chicago, Medical Center, Maywood, Illinois 60153.

出版信息

Gynecol Oncol. 1993 Feb;48(2):232-5. doi: 10.1006/gyno.1993.1039.

Abstract

DNA analysis by flow cytometry has been reported to be a useful prognostic technique for a variety of malignant tumors. The goal of this study was to examine DNA ploidy status and proliferation index as potential predictors of recurrence and survival for patients with squamous cell vulvar carcinomas. The DNA ploidy, percentage of cells in the S-phase of the cell cycle, stage, and histologic grade were analyzed in 42 patients. Flow cytometry was performed on archival paraffin-embedded tissue. The histologic specimens were reviewed by a single pathologist. Thirty-four tumors (81%) were diploid and eight (19%) demonstrated an aneuploid peak. The percentage of cells in the S-phase (proliferation index) was calculated for all patients. The 5-year survival rate was 68% for diploid tumors and was 75% for aneuploid tumors. The difference between these rates was not statistically significant (P < or = 0.65). S-phase fraction was also not a useful predictor for recurrence or overall survival. FIGO stage and histologic grade were accurate predictors for both recurrence and 5-year survival. Multiple predictor analysis using stage, grade, ploidy status, and proliferation index did not identify any subgroup which would predict recurrence better than FIGO stage and grade. DNA ploidy and S-phase fraction analysis do not appear to be clinically useful prognostic factors for vulvar squamous cell carcinomas.

摘要

据报道,通过流式细胞术进行DNA分析是一种对多种恶性肿瘤有用的预后技术。本研究的目的是检查DNA倍体状态和增殖指数,作为外阴鳞状细胞癌患者复发和生存的潜在预测指标。对42例患者的DNA倍体、细胞周期S期细胞百分比、分期和组织学分级进行了分析。在存档的石蜡包埋组织上进行流式细胞术检测。组织学标本由一位病理学家复查。34个肿瘤(81%)为二倍体,8个(19%)显示非整倍体峰。计算了所有患者的S期细胞百分比(增殖指数)。二倍体肿瘤的5年生存率为68%,非整倍体肿瘤为75%。这些比率之间的差异无统计学意义(P≤0.65)。S期分数也不是复发或总生存的有用预测指标。国际妇产科联盟(FIGO)分期和组织学分级是复发和5年生存的准确预测指标。使用分期、分级、倍体状态和增殖指数进行的多因素预测分析未发现任何比FIGO分期和分级能更好地预测复发的亚组。DNA倍体和S期分数分析似乎不是外阴鳞状细胞癌临床上有用的预后因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验